Additionally, GLP-1 modulates the phosphorylation of AKT, ERK, GSK-3B, and mTOR to increase cell viability and growth (25, 26)
Always aim the needle at the vial wall and let water trickle down gently
Previously approved by the Therapeutic Goods Administration (TGA) for obesity and, in February 2025, for reducing cardiovascular risks in overweight patients with heart disease, it joins siblings like Ozempic (for diabetes) in addressing Australia's obesity epidemic, where over 30% of adults are obese per national health surveys
[13] An alternate study conducted by REWIND [17] had enrolled a lower-risk population consisting of 9901 patients, two-thirds had no prior cardiovascular events
Knowing what success looks like for you is the first step